Physician profile
Erik C Spayde
NPI 1609818822
$1,177,673.63
in general payments reported to CMS, 2019-2025
63 companies · $80K in 2025
The $80K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $718K · 2020: $60K · 2021: $67K · 2022: $92K · 2023: $92K · 2024: $69K · 2025: $80K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $190K · Consulting Fee: $32K · Food and Beverage: $9,748 · Travel and Lodging: $7,427 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $190,124.45 |
| Consulting Fee | $32,138.92 |
| Food and Beverage | $9,747.86 |
| Travel and Lodging | $7,427.31 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $695,796.22 | 2019-2023 | Pulse, Alif, Attrax |
| Biogennix, LLC | $372,143.72 | 2019-2025 | Morpheus, Agilon |
| The Institute of Musculoskeletal Science and Education | $42,561.76 | 2020-2025 | Spira, Orthros |
| Orthofix Medical, INC. | $23,265.38 | 2023-2025 | Miscellaneous, Northstar, Mariner |
| Seaspine Orthopedics Corporation | $9,343.32 | 2019-2022 | |
| Arteriocyte Medical Systems, INC. | $6,608.50 | 2019-2025 | Magellan |
| Globus Medical, INC. | $4,668.77 | 2020-2025 | Pulse, Xlif, Excelsiusgps Robotic Navigation System |
| Camber Spine Technologies LLC | $4,270.08 | 2019-2023 | |
| Axiomed LLC | $2,973.24 | 2023-2025 | Freedom Lumbar Disc |
| Baxter Healthcare | $2,798.44 | 2019-2024 | Floseal |
| Surgalign Spine Technologies, INC. | $1,924.96 | 2019-2022 | |
| Spinefrontier, INC. | $1,605.48 | 2021-2024 | Nanofuse, Inspan, Sacrix |
| Biotronik Nro, INC. | $1,186.65 | 2023-2025 | Prospera, Biotronik |
| Boston Scientific Corporation | $1,030.36 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $862.07 | 2021-2025 | Aquamantys(Tm), Radialux, Plasmablade(Tm) |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $833.58 | 2019-2025 | |
| Abbott Laboratories | $831.92 | 2019-2025 | Proclaim |
| Merit Medical Systems INC | $795.65 | 2021-2025 | Star Tumor Ablation System, Stabilit System |
| Corelink, LLC | $339.80 | 2022-2023 | |
| Radius Health, INC. | $301.09 | 2019-2024 | Tymlos |
| Captiva Spine INC | $216.49 | 2021 | |
| Cerapedics INC. | $213.91 | 2020-2021 | |
| Stryker Corporation | $206.82 | 2019-2022 | |
| Nevro Corp. | $179.24 | 2022-2023 | Senza |
| Foundation Fusion Solutions, LLC | $163.28 | 2020 | |
| Augmedics INC. | $160.94 | 2023-2024 | Xvision |
| Si-Bone, INC. | $160.88 | 2021-2024 | |
| Centinel Spine, LLC | $157.63 | 2025 | Prodisc C Vivo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $152.28 | 2021-2022 | |
| Xtant Medical INC | $143.53 | 2024 | |
| Djo, LLC | $140.13 | 2022-2025 | Aircast, Procare |
| Amgen INC. | $131.41 | 2021-2025 | Evenity, Prolia |
| Stimwave Technologies Incorporated | $129.68 | 2022 | |
| Ethicon US, LLC | $105.89 | 2019-2021 | |
| Spineology INC. | $94.22 | 2020-2022 | |
| Horizon Therapeutics Plc | $90.51 | 2019-2020 | |
| Painteq LLC | $83.60 | 2022 | |
| Spineart USA INC | $80.45 | 2020 | |
| Ge Healthcare | $76.83 | 2025 | |
| Medtronic USA, INC. | $66.15 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $61.15 | 2024-2025 | |
| Curonix LLC | $51.65 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Alphatec Spine, INC | $49.84 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $49.15 | 2022-2023 | Seglentis |
| Saxum Surgical, INC. | $47.76 | 2023 | |
| Vertiflex, INC. | $47.06 | 2019 | |
| Fidia Pharma USA INC. | $46.69 | 2022-2023 | Hymovis, Triluron |
| Grt US Holding, INC. | $45.09 | 2022 | |
| Integra Lifesciences Corporation | $44.78 | 2019-2021 | |
| Spr Therapeutics, INC | $35.76 | 2025 | Sprint Pns System |
| Electronic Waveform Lab, INC. | $32.91 | 2019 | |
| Edwards Lifesciences Corporation | $32.85 | 2020 | |
| Bioventus LLC | $30.52 | 2022 | |
| Spinal Simplicity, LLC | $28.50 | 2020-2021 | |
| Abbvie INC. | $27.90 | 2021 | |
| Relievant Medsystems, INC. | $27.02 | 2021 | |
| Davol INC. | $23.38 | 2023 | |
| Vertos Medical, INC. | $23.25 | 2022 | |
| Collegium Pharmaceutical, INC. | $21.30 | 2024 | Belbuca |
| Innovation Technologies INC | $18.88 | 2022 | |
| Intrinsic Therapeutics | $15.50 | 2023 | Barricaid Acd (Annular Closure Device) |
| Forte Bio-Pharma LLC | $10.71 | 2019 | |
| Terumo Bct, INC. | $7.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$600.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$8,000,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Spayde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.